Alexia Alfaro
Villejuif, 94800, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Efficacy, safety, and biomarker analysis of datopotamab deruxtecan in advanced non-small cell lung cancer: ICARUS-LUNG01 phase 2 study.
Journal: Cancer cell
Published: July 07, 2025
Patritumab deruxtecan in HR+HER2- advanced breast cancer: a phase 2 trial.
Journal: Nature medicine
Published: March 31, 2025
Author Correction: Characterization and spatial distribution of infiltrating lymphocytes in medullary, and lymphocyte-predominant triple negative breast cancers.
Journal: NPJ breast cancer
Published: October 25, 2024
Gut Microbiota Modulation through Akkermansia spp. Supplementation Increases CAR T-cell Potency.
Journal: Cancer discovery
Published: August 28, 2024
CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemia.
Journal: The Journal of clinical investigation
Published: February 28, 2024
Deleting Trim33 in Myeloid Cells Improves the Efficiency of Radiotherapy through an IFNβ-Dependent Antitumor Immune Response.
Journal: Cancer immunology research
Published: January 09, 2024
Characterization and spatial distribution of infiltrating lymphocytes in medullary, and lymphocyte-predominant triple negative breast cancers.
Journal: NPJ breast cancer
Published: December 08, 2023
Immune checkpoints are predominantly co-expressed by clonally expanded CD4+FoxP3+ intratumoral T-cells in primary human cancers.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 14, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial.
Journal: Nature medicine
Published: September 20, 2022
Low Doses of Radiation Increase the Immunosuppressive Profile of Lung Macrophages During Viral Infection and Pneumonia.
Journal: International journal of radiation oncology, biology, physics
Published: January 07, 2021
Last Updated: 09/26/2026